Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_provenance.
- NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_assertion description "[Expression of dominant-negative PPARgamma reverses transcriptional activation of 15-lipoxygenase-2 promoter by enhancing it 202-fold in normal prostate epithelial cells or suppressing it in prostate carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_provenance.
- NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_assertion evidence source_evidence_literature NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_provenance.
- NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_assertion SIO_000772 16682954 NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_provenance.
- NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_assertion wasDerivedFrom lhgdn-20090331 NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_provenance.
- NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_assertion wasGeneratedBy ECO_0000203 NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_provenance.
- lhgdn-20090331 importedOn "2009-03-31" NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_provenance.